On this page
What these therapies are — and what they aren't
Two broad categories get grouped under 'regenerative' for joints. Platelet-rich plasma (PRP) concentrates platelets from your own blood and injects them into the joint or tendon. Cell-based therapies use cells derived from your own bone marrow or adipose tissue, prepared and injected under imaging guidance.
What they are not: a replacement for a joint replacement. No injection regrows a joint that has lost its cartilage. The realistic goal is symptom modification and functional improvement in appropriately selected patients — most often those with mild to moderate osteoarthritis or specific tendinopathies who are not yet at the surgical threshold.
Where the evidence actually stands
We grade this honestly rather than selling it, because this is the corner of medical travel with the most marketing and the least rigor. Broadly:
- Strongest relative evidence: PRP for knee osteoarthritis and for certain tendinopathies, where multiple randomized trials exist — though preparation protocols differ so much between studies that comparing them is genuinely difficult.
- Mixed and developing: cell-based injection therapy for knee osteoarthritis, where early trial results are encouraging in places but protocols, cell sources and dosing are not standardized.
- Weak or preliminary: most applications outside the knee, most claims about cartilage regeneration, and essentially all claims of cure.
The regulatory point that matters. Cell-based therapies occupy different regulatory categories in different countries. In Colombia, INVIMA is the national regulator; in the United States, the FDA regulates these products and many marketed applications are not FDA-approved. A clinic offering a therapy abroad is not evidence that the therapy works — it may simply reflect a different regulatory environment. Ask what specifically is being injected, how it's prepared, and under what registration or authorization.
Who these therapies suit
Reasonable candidates tend to have mild to moderate radiographic arthritis, symptoms that limit activity but haven't destroyed function, no mechanical locking or bone-on-bone collapse, realistic expectations, and a willingness to combine the injection with the boring work — weight management, strengthening and load modification — that actually drives most of the improvement.
Poor candidates: end-stage arthritis with bone-on-bone contact and deformity, active infection, certain blood or clotting disorders, active malignancy, and anyone hoping to avoid a replacement that they clearly already need. Delaying an indicated replacement in favor of repeated injections can cost you function you don't get back.
Cost, and why the price argument is weaker here
Typical 2026 U.S. self-pay pricing runs roughly $5,000 to $10,000; typical Colombian pricing runs roughly $2,850 to $8,500. Market ranges, not quotes.
Note that these ranges overlap. That's unusual on this site and it's worth saying plainly: unlike joint replacement, where the gap is enormous and unambiguous, the savings on injection therapy can be modest once you add airfare and a week of accommodation. If cost is your only reason to travel for PRP, run the arithmetic honestly first.
What to ask before booking
- Exactly what is being injected — PRP, bone marrow concentrate, adipose-derived preparation, something else?
- How is it prepared, and by whom? Is the protocol documented?
- Is the injection performed under ultrasound or fluoroscopic guidance?
- What is the regulatory status of this specific product in Colombia?
- How many sessions are proposed, and what's the total cost of the full course?
- What outcome measure will we use, and at what interval, to decide whether it worked?
- What happens if it doesn't work — what's the next step?
Any facility that answers 'it works for everyone' to the last question has answered every question you needed answered.
Common questions
Can regenerative therapy help me avoid a knee replacement?
It may delay surgery for some patients with mild to moderate arthritis and manageable symptoms. It cannot regrow a joint that has already collapsed, and delaying a clearly indicated replacement can cost function that doesn't come back. The honest framing is symptom modification in selected patients, not cure or avoidance.
How many sessions will I need?
Protocols vary widely between facilities, which is itself informative about how standardized the field isn't. Ask for the full proposed course and the total cost up front rather than paying per session and discovering the plan as you go.
Is it covered by insurance?
Rarely, in any country. Assume you're paying cash. That's true domestically as well, which is part of why the price comparison here is closer than it is for surgery.
Is it safe?
Injection procedures carry the usual risks of infection, bleeding, pain flare and, rarely, damage to structures near the injection site. Autologous preparations avoid donor-related risks. The larger concern in this field is less physical safety than financial and opportunity cost — paying substantially for a therapy with uncertain benefit while deferring an intervention that would have helped.
How will I know if it worked?
Agree the measure before you start: pain scores, a validated functional score, walking distance, or specific activities you can't currently do. Assess it over months against your own baseline. Judging by how you feel the week after an injection tells you almost nothing.